...Danqing Zhao; Shaoxuan Hu; Daobin Zhou; Yan Zhang; Wei Wang; Wei Zhang Introduction: The clinical implications of plasma Epstein-Barr virus (EBV) DNA in patients with peripheral T-cell lymphoma (PTCL) remain unclear. Objective: This study aimed to explore the clinical correlations of pre- and post...

...). Here, we describe a patient who presented with apparent Epstein-Barr virus (EBV)-associated immune thrombocytopenia resistant to several lines of therapies, which was in fact a form of AAT with some features of AA. He eventually responded to therapy with eltrombopag, cyclosporine A (CSA...

... pleuritis. We report the first case of Epstein-Barr virus (EBV)-positive PAL arising from a posttraumatic empyema. A 75-year-old woman with chronic posttraumatic empyema presented with a tumor, which was connected to the wall of a pyothorax in the right thoracic cavity. She had a history of trauma...

...S. Al-Humood; A. AlQallaf; S. Al-Shemmari; L. Al-Faris; B. Al-Ayadhy Epstein-Barr virus (EBV) has a pathogenic role in several lymphomas, including diffuse large B-cell lymphoma (DLBCL). EBV-associated genetic aberrations in DLBCL have not been fully characterized. The aim of this study...

... gene sequences of human herpesvirus-8 (HHV-8) and Epstein-Barr virus (EBV). Tumor cells of HIV-negative patients usually express HHV-8 gene sequences, but rarely those of EBV. We report a novel case of PEL in an HIV-negative homosexual male whose tumor cells expressed both HHV-8 and EBV gene sequences...

...Kinya Ohata; Noriko Iwaki; Takeharu Kotani; Yukio Kondo; Hirohito Yamazaki; Shinji Nakao Lymphoproliferative disorders (LPDs) are generally caused by uncontrolled B-cell proliferation induced by the Epstein-Barr virus (EBV) in the setting of impaired EBV-specific T-cell immunity, particularly when...

...R.J.L. Davidson; S.E. Lessels A patient who developed infectious mononucleosis while being treated for Hodgkin’s disease is presented. This pathological profile does not support the concept of a causal relationship between Epstein-Barr virus and Hodgkin’s disease. 3 3 2009 © 1977 S...

.... Burkitt s tumour Epstein-Barr virus Leukaemia in Burkitt s lym­ phoma Methylgreen-pyronine Abstract. A Nigerian male child presented with extensive superficial lymphadenopathy, a bleeding diathesis, and numerous tumour cells in blood and bone marrow. Further characterization of the tumour cells...

...M.M.A.C. Langenhuysen The case is presented of a patient, treated for Hodgkin’s disease, who contracted infectious mononucleosis more than 3 years later. While Epstein-Barr virus has been considered a possible etiologic factor in Hodgkin’s disease, the sequence of events reported in this case has...

...S. Yoshimoto; S. Yano; M. Yamashita; H. Taguchi; Y. Kamimura; Y. Ohtsuki; I. Miyoshi A 54-year-old man developed primary brain lymphoma after immunosuppressive treatment for immunoblastic lymphadenopathy. The lymphoma cells were positive for the Epstein-Barr virus genome and had the surface...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. CD21 Epstein-Barr virus Hairy cell leukaemia Interleukin-6 Original Paper Acta Haematol 1994;92:8-13 Takeshi Tokiokaa Yoshinori Shimamotoa Fumio Nagumob Jutaro Tadanob Masaya...

... of cytomegalovirus (CMV) and Epstein-Barr virus (EBV) by using in situ hybridization (ISH) and also evaluated the clinical and laboratory findings according to the encountered organisms. ISH using a CMV RNA probe demonstrated infected cells in 6 out of 14 cases (43%), and ISH using an EBV EBER RNA probe demonstrated...

...Martin Simon; Bettina Borisch; Berno Heymer Patients with primary or secondary immunodeficiency are at high risk for B cell lymphoproliferative syndromes (LPS) that are generally Epstein-Barr virus (EBV)-associated. We established a cell line, termed JuWa, from an immunoblastic lymphoma...

...Hiroyuki Watanabe; Msahiko Koide; Kunihiko Fukuchi; Ysushi Takagi; Shigeru Tomoyasu; Nobuyoshi Tsuruoka; Kunihide Gomi The Epstein-Barr virus (EBV) genome was detected by polymerase chain reaction (PCR) in mononuclear cells from bone marrows with diverse types of hematopoietic malignancies. Viral...

...Young Hyeh Ko; Sanghui Park; Kihyun Kim; Seok Jin Kim; Won Seog Kim Aggressive natural killer (NK) cell leukemia (ANKL) is a prototype of an Epstein-Barr virus (EBV)-associated lymphoid malignancy, which is characterized by a fulminant clinical course and a median survival interval <2 months...

... by large blastic B cells with an association of Epstein-Barr virus. Southern blot study demonstrated the clonal rearrangement of T cell receptor β-chain gene, but not of immunoglobulin heavy chain gene. Phenotypical examination of the lymph node also revealed the predominance of CD4+ T cells in addition...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. CD20 Epstein-Barr virus Pyothorax-associated lymphoma THP-COP therapy...

...M. Helen Huls; Cliona M. Rooney; Helen E. Heslop Immunotherapy approaches with antigen-specific cytotoxic T lymphocytes (CTLs) have proved safe and effective prophylaxis and treatment of Epstein-Barr virus (EBV)-associated lymphomas arising after bone marrow transplantation. EBV is also associated...

... is Epstein-Barr virus (EBV). EBV-associated post-transplant lymphoproliferative disorder (PTLD) is a serious complication post-solid organ transplant (SOT) or hematopoietic stem cell transplant (HSCT). The disease is essentially the result of suppression of cytotoxic T-cell function and despite various...

... Sarcoidosis CD16 CD56 CD57 Epstein-Barr virus Large granular lymphocytes (LGLs) represent a morphologically characteristic subset accounting for up to 15% of blood lymphocytes. In Wright-Giemsa-stained smears they are larger than small lymphocytes, have an indented or round nucleus and contain...